Close Menu

NEW YORK (GenomeWeb) – FDNA said today that it is collaborating with clinical genetics laboratories GeneDx and Blueprint Genetics, who will integrate its phenotyping software into their workflow.

The collaboration "will fully integrate FDNA's analysis into the genetic testing workflow of these labs by enabling clinicians to share phenotypic data with these labs in real time," according to the company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.